# Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

> **NCT00263614** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00263614
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263614, "Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00263614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*